| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0950-3536(05)80103-9 |
| P698 | PubMed publication ID | 7841605 |
| P2093 | author name string | Humphries S | |
| Green F | |||
| P2860 | cites work | DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration | Q28257917 |
| Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters | Q28299313 | ||
| Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease | Q34117320 | ||
| Plasminogen activator inhibitor in the blood of patients with coronary artery disease | Q34490676 | ||
| The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review | Q35450766 | ||
| Control of plasma fibrinogen levels | Q38737722 | ||
| Population-based distributions of haemostatic variables | Q39708097 | ||
| The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene | Q40545045 | ||
| Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency | Q41098606 | ||
| Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells | Q41780622 | ||
| Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations | Q41887737 | ||
| Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor | Q41963335 | ||
| Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet | Q41994945 | ||
| The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element | Q42153397 | ||
| Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease | Q43690509 | ||
| An epidemiological study of the haemostatic and other effects of oral contraceptives | Q43841974 | ||
| Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. | Q44729331 | ||
| The triglyceride issue: a view from Framingham | Q44822390 | ||
| Genetic and cultural inheritance of plasma fibrinogen concentration | Q47391741 | ||
| Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. | Q51608271 | ||
| Hypertriglyceridaemia and hypercoagulability | Q51647241 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations | Q66904521 | ||
| Fibrinogen genotype and risk of peripheral atherosclerosis | Q67514520 | ||
| A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals | Q67689460 | ||
| Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment | Q67720940 | ||
| Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study | Q68037615 | ||
| Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity | Q68290719 | ||
| The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit | Q68755623 | ||
| Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway | Q68816464 | ||
| Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus | Q69018082 | ||
| Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response | Q69068473 | ||
| Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality | Q69564264 | ||
| Risk of stroke in male cigarette smokers | Q69598475 | ||
| Clotting factors VII and X as useful markers of terminal deletion of chromosome 13 | Q69833361 | ||
| Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease | Q69864970 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 | ||
| Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease | Q69908116 | ||
| Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction | Q69973450 | ||
| Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations | Q70322551 | ||
| Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study | Q70731158 | ||
| Defective fibrinolysis in survivors of myocardial infarction | Q70797052 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study | Q71997888 | ||
| Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 | ||
| Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR | Q72669969 | ||
| Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men | Q72690028 | ||
| Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets | Q72762754 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 675-692 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Best Practice and Research: Clinical Haematology | Q15755888 |
| P1476 | title | Genetic determinants of arterial thrombosis | |
| P478 | volume | 7 |
Search more.